In a groundbreaking development that could revolutionize early detection of Alzheimer’s disease, researchers are exploring ...

Alzheimer's disease—the most common form of dementia—is a progressive neurological disorder that causes brain cells to ...

It was the third failed trial for the therapy, called dalzanemdor, which also failed to meet its goals in a Phase 2 trial as ...

Alzheimer's disease affects more than 50 million people worldwide, often devastating both the individuals who have it and their families and loved ones.

Alzheimer’s is a disease that knows no stranger. “It’s actually the seventh leading cause of death in the United States,” ...

A breakthrough in the fight against Alzheimer’s disease may have been made in Seattle. Researchers at the Allen Institute ...

Alzheimer's is one of the most progressive neurodegenerative diseases as it impacts millions across the globe. According to experts, lifestyle factors and other environmental elements contribute to ...

In a recent study, Tel Aviv Sourasky Medical Center has shed light on physician attitudes toward novel anti-amyloid ...

People with Alzheimer’s exhibit a loss of motor control along with cognitive decline, and one of the earliest signs of this ...

Researchers from Emory University recently received two separate grants, totaling $15 million, from the National Institutes ...

- VY1706 is the fifth neuro gene therapy development candidate nominated leveraging Voyager’s IV-delivered, CNS-penetrant TRACER capsids - ...

Here are 10 healthy habits for our brain suggested by the Alzheimer’s Association. Challenge your mind. Learn something new ...